Filing Details
- Accession Number:
- 0001144204-18-050799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-25 20:41:34
- Reporting Period:
- 2018-09-21
- Accepted Time:
- 2018-09-25 20:41:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1722964 | Y-Mabs Therapeutics Inc. | YMAB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1245624 | James Healy | C/O Sofinnova Ventures, Inc., 3000 Sand Hill Road, Bldg. 4, Suite 250 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-21 | 500,000 | $16.00 | 2,104,278 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- Such shares of the Company's Common Stock are owned by Sofinnova Venture Partners X, L.P. ("Sofinnova X"). The Reporting Person is a managing member of Sofinnova Management X, L.L.C., the General Partner of Sofinnova X, and as such has shared voting and dispositive power over such shares with Dr. Anand Mehra and Michael F. Powell, Ph.D., the other managing members of Sofinnova Management X, L.L.C. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein.